{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:06:22Z","timestamp":1774883182115,"version":"3.50.1"},"reference-count":73,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205685","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T15:04:12Z","timestamp":1711379052000},"source":"Crossref","is-referenced-by-count":4,"title":["Novel insights into the pathogenesis of thyroid eye disease through ferroptosis-related gene signature and immune infiltration analysis"],"prefix":"10.18632","author":[{"given":"Yunyan","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo 315040, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo 315040, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mugaanyi","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo 315040, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weina","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo 315040, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo 315040, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"1","first-page":"177","article-title":"Current Diagnosis and Management of Graves\u2019 Disease.","volume":"5","author":"Pramono","year":"2018","journal-title":"Acta Med Indones"},{"key":"2","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 Disease.","volume":"37","author":"Heged\u00fcs","year":"2016","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed graves\u2019 hyperthyroidism seen at a single center.","volume":"9","author":"Bartalena","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"4","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1167\/iovs.14-14002","article-title":"Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.","volume":"5","author":"Smith","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy.","volume":"36","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy.","volume":"5","author":"Wiersinga","year":"2016","journal-title":"Eur Thyroid J"},{"key":"7","doi-asserted-by":"publisher","first-page":"615993","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, Natural History, Risk Factors, and Prevention of Graves\u2019 Orbitopathy.","volume":"1","author":"Tanda","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.medcli.2020.07.031","article-title":"Treatment of Graves\u2019 ophthalmopathy.","volume":"15","author":"Sales-Sanz","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","article-title":"Immunopathogenesis of Graves\u2019 ophthalmopathy: the role of the TSH receptor.","volume":"2","author":"Bahn","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1210\/jc.2011-0307","article-title":"Autoimmunity in Graves\u2019 ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?","volume":"9","author":"Wiersinga","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1089\/thy.2014.0218","article-title":"Glucocorticoid regimens for prevention of Graves\u2019 ophthalmopathy progression following radioiodine treatment: systematic review and meta-analysis.","volume":"2","author":"Robenshtok","year":"2014","journal-title":"Thyroid"},{"key":"12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.beem.2011.11.002","article-title":"Surgical treatment of Graves\u2019 ophthalmopathy.","volume":"2","author":"Esser","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1055\/s-0043-116945","article-title":"Combination Therapy of Intravenous Steroids and Orbital Irradiation is More Effective Than Intravenous Steroids Alone in Patients with Graves\u2019 Orbitopathy.","volume":"4","author":"Eckstein","year":"2017","journal-title":"Horm Metab Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/EJE-16-0552","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves\u2019 orbitopathy - lessons from randomized control trials.","volume":"17","author":"Salvi","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"15","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for Thyroid-Associated Ophthalmopathy.","volume":"37","author":"Shriver","year":"2017","journal-title":"N Engl J Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0035-1555762","article-title":"Current Insights into the Pathogenesis of Graves\u2019 Ophthalmopathy.","volume":"4","author":"Bahn","year":"2015","journal-title":"Horm Metab Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1365-2265.2009.03753.x","article-title":"The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves\u2019 ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.","volume":"7","author":"Wall","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12022-015-9373-8","article-title":"Latent Pathways Identification by Microarray Expression Profiles in Thyroid-Associated Ophthalmopathy Patients.","volume":"2","author":"Liu","year":"2015","journal-title":"Endocr Pathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"5961974","DOI":"10.1155\/2018\/5961974","article-title":"PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy.","volume":"201","author":"Wei","year":"2018","journal-title":"Biomed Res Int"},{"key":"20","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1167\/iovs.17-22237","article-title":"RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy.","volume":"5","author":"Wester","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1874364101812010041","article-title":"Transcriptome Analysis of Orbital Adipose Tissue in Active Thyroid Eye Disease Using Next Generation RNA Sequencing Technology.","volume":"1","author":"Korn","year":"2018","journal-title":"Open Ophthalmol J"},{"key":"22","doi-asserted-by":"publisher","first-page":"571151","DOI":"10.3389\/fendo.2020.571151","article-title":"Microarray Data of Lacrimal Gland Implicates Dysregulated Protein Processing in Endoplasmic Reticulum in Graves\u2019 Ophthalmopathy.","volume":"1","author":"Shi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"23","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jamaophthalmol.2017.3458","article-title":"Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland.","volume":"13","author":"Edward","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.yexmp.2015.07.002","article-title":"Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling.","volume":"9","author":"Alabiad","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.yexmp.2015.01.009","article-title":"Molecular diagnosis of orbital inflammatory disease.","volume":"9","author":"Planck","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1001\/jamaophthalmol.2015.0726","article-title":"Parallel Gene Expression Changes in Sarcoidosis Involving the Lacrimal Gland, Orbital Tissue, or Blood.","volume":"13","author":"Alabiad","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1136\/bjophthalmol-2015-306614","article-title":"Fibrosis, gene expression and orbital inflammatory disease.","volume":"9","author":"Dubovy","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"28","doi-asserted-by":"publisher","first-page":"e0137654","DOI":"10.1371\/journal.pone.0137654","article-title":"The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment.","volume":"1","author":"Alabiad","year":"2015","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments.","volume":"2","author":"Storey","year":"2012","journal-title":"Bioinformatics"},{"key":"30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-93791-5_2","article-title":"Data Analysis Using R Programming.","volume":"108","author":"Chan","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"31","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data.","volume":"3","author":"Schlesner","year":"2016","journal-title":"Bioinformatics"},{"key":"32","doi-asserted-by":"publisher","first-page":"678877","DOI":"10.3389\/fmolb.2021.678877","article-title":"A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.","volume":"8","author":"Tang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"33","doi-asserted-by":"publisher","first-page":"726656","DOI":"10.3389\/fcell.2021.726656","article-title":"Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis.","volume":"9","author":"Ouyang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-019-0730-1","article-title":"Statistical predictions with glmnet.","volume":"1","author":"Bohlin","year":"2019","journal-title":"Clin Epigenetics"},{"key":"35","doi-asserted-by":"publisher","first-page":"11944","DOI":"10.1038\/s41598-022-16155-w","article-title":"Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma.","volume":"1","author":"Lu","year":"2022","journal-title":"Sci Rep"},{"key":"36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12874-016-0209-0","article-title":"A computational approach to compare regression modelling strategies in prediction research.","volume":"1","author":"Groenwold","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"37","doi-asserted-by":"publisher","first-page":"e202219059","DOI":"10.1002\/anie.202219059","article-title":"Akaike\u2019s Information Criterion for Stoichiometry Inference of Supramolecular Complexes.","volume":"6","author":"Isobe","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.0006-341x.2001.00120.x","article-title":"Akaike\u2019s information criterion in generalized estimating equations.","volume":"5","author":"Pan","year":"2001","journal-title":"Biometrics"},{"key":"39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mbs.2018.06.004","article-title":"The Bayesian adaptive lasso regression.","volume":"30","author":"Ali","year":"2018","journal-title":"Math Biosci"},{"key":"40","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/jgh.15873","article-title":"GESA Statement on the timing of elective endoscopic procedures in patients with recent COVID-19 infection.","volume":"3","author":"Devereaux","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection.","volume":"1","author":"Tamayo","year":"2015","journal-title":"Cell Syst"},{"key":"42","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.","volume":"2","author":"Yu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis.","volume":"9","author":"Horvath","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"45","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.","volume":"4","author":"von Mering","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"1","author":"Ideker","year":"2003","journal-title":"Genome Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape Automation: empowering workflow-based network analysis.","volume":"2","author":"Demchak","year":"2019","journal-title":"Genome Biol"},{"key":"48","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome.","volume":"8","author":"Lin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40510-021-00377-1","article-title":"MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis.","volume":"2","author":"Aishwarya","year":"2021","journal-title":"Prog Orthod"},{"key":"50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry.","volume":"3","author":"Alizadeh","year":"2019","journal-title":"Nat Biotechnol"},{"key":"51","doi-asserted-by":"publisher","first-page":"13639","DOI":"10.1038\/s41598-022-17954-x","article-title":"Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model.","volume":"1","author":"Lu","year":"2022","journal-title":"Sci Rep"},{"key":"52","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/CIRCULATIONAHA.116.026361","article-title":"Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1.","volume":"13","author":"Gleason","year":"2017","journal-title":"Circulation"},{"key":"53","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation Coefficients: Appropriate Use and Interpretation.","volume":"12","author":"Schwarte","year":"2018","journal-title":"Anesth Analg"},{"key":"54","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1210\/clinem\/dgac252","article-title":"Future Projections in Thyroid Eye Disease.","volume":"10","author":"Freitag","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11910-022-01194-7","article-title":"Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy.","volume":"2","author":"Kossler","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"key":"56","doi-asserted-by":"publisher","first-page":"101843","DOI":"10.1016\/j.clae.2023.101843","article-title":"Corneal topographic changes in patients with thyroid eye disease: A retrospective cross-sectional study.","volume":"4","author":"Chien","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"key":"57","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1080\/02713683.2020.1776331","article-title":"Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.","volume":"4","author":"Saxena","year":"2020","journal-title":"Curr Eye Res"},{"key":"58","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2021.04.024","article-title":"Teprotumumab: Interpreting the Clinical Trials in the Context of Thyroid Eye Disease Pathogenesis and Current Therapies.","volume":"12","author":"Kersten","year":"2021","journal-title":"Ophthalmology"},{"key":"59","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/hep.28574","article-title":"Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.","volume":"6","author":"Tang","year":"2016","journal-title":"Hepatology"},{"key":"60","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3892\/ijo.2018.4259","article-title":"Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.","volume":"5","author":"Kumakura","year":"2018","journal-title":"Int J Oncol"},{"key":"61","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","article-title":"The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma.","volume":"2","author":"Chi","year":"2019","journal-title":"Cell Rep"},{"key":"62","doi-asserted-by":"publisher","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.","volume":"7","author":"Gibson","year":"2016","journal-title":"Cell Death Dis"},{"key":"63","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy.","volume":"11","author":"Dai","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"64","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1007\/s12035-018-1403-3","article-title":"Ferroptosis and Its Role in Diverse Brain Diseases.","volume":"5","author":"Wang","year":"2019","journal-title":"Mol Neurobiol"},{"key":"65","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/hep.25828","article-title":"Human antigen R contributes to hepatic stellate cell activation and liver fibrosis.","volume":"5","author":"Mart\u00ednez-Chantar","year":"2012","journal-title":"Hepatology"},{"key":"66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease.","volume":"2","author":"Conrad","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"67","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1200\/JCO.2005.05.183","article-title":"Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children\u2019s Cancer Group Study.","volume":"2","author":"Matthay","year":"2005","journal-title":"J Clin Oncol"},{"key":"68","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","article-title":"MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-\/Glutathione Axis.","volume":"8","author":"Swift","year":"2021","journal-title":"Cancer Res"},{"key":"69","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/gut.48.3.367","article-title":"Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.","volume":"4","author":"Bodmer","year":"2001","journal-title":"Gut"},{"key":"70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/tpj.2014.24","article-title":"Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial.","volume":"1","author":"Robert","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"71","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.","volume":"7","author":"Oh","year":"2021","journal-title":"JAMA Oncol"},{"key":"72","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41419-019-1984-4","article-title":"The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis.","volume":"1","author":"Yuan","year":"2019","journal-title":"Cell Death Dis"},{"key":"73","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.18240\/ijo.2018.09.09","article-title":"Biomarker identification of thyroid associated ophthalmopathy using microarray data.","volume":"1","author":"Zhang","year":"2018","journal-title":"Int J Ophthalmol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T15:04:15Z","timestamp":1711379055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":73,"alternative-id":["205685"],"URL":"https:\/\/doi.org\/10.18632\/aging.205685","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]}}}